Physician profile
Robert B Maximos
NPI 1962732040
$6,936.16
in general payments reported to CMS, 2019-2025
8 companies · $608 in 2025
The $608 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $11.42 · 2022: $2,103 · 2023: $4,039 · 2024: $50.66 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $711 · Food and Beverage: $587 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $711.12 |
| Food and Beverage | $586.52 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,703.11 | 2023 | Ion, Da Vinci Surgical System |
| Pinnacle Biologics, INC | $2,076.32 | 2022 | |
| Noah Medical Corporation | $461.31 | 2025 | Galaxy |
| Pulmonx Corporation | $342.88 | 2022-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Medtronic, INC. | $192.26 | 2023-2024 | Signia, Illumisite |
| Astrazeneca Pharmaceuticals LP | $124.03 | 2019 | |
| Abbvie INC. | $24.83 | 2025 | |
| Veran Medical Technologies, INC. | $11.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Maximos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.